+Compare
JNJ
Stock ticker: NYSE
AS OF
Loading...
Price
Loading...
Change
Loading...
Capitalization
374.06B

JNJ Johnson & Johnson Forecast, Technical & Fundamental Analysis

an investment holding company with interests in health care products

Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
A.I.Advisor
a Summary for JNJ with price predictions
08:00 PM EDT Oct 02, 2023

JNJ in downward trend: 10-day moving average broke below 50-day moving average on August 31, 2023

The 10-day moving average for JNJ crossed bearishly below the 50-day moving average on August 31, 2023. This indicates that the trend has shifted lower and could be considered a sell signal. In of 20 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on September 22, 2023. You may want to consider selling the stock, shorting the stock, or exploring put options on JNJ as a result. In of 81 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for JNJ turned negative on September 25, 2023. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 49 similar instances when the indicator turned negative. In of the 49 cases the stock turned lower in the days that followed. This puts the odds of success at .

JNJ moved below its 50-day moving average on August 28, 2023 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where JNJ declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for JNJ entered a downward trend on October 03, 2023. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator shows that the ticker has stayed in the oversold zone for 4 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 6 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where JNJ advanced for three days, in of 331 cases, the price rose further within the following month. The odds of a continued upward trend are .

JNJ may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

Fear & Greed

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.973) is normal, around the industry mean (6.095). P/E Ratio (31.447) is within average values for comparable stocks, (31.737). Projected Growth (PEG Ratio) (5.129) is also within normal values, averaging (3.297). Dividend Yield (0.030) settles around the average of (0.028) among similar stocks. P/S Ratio (4.196) is also within normal values, averaging (3.700).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 66, placing this stock better than average.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. JNJ’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Eli Lilly & Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), ABBVIE (NYSE:ABBV), Merck & Co (NYSE:MRK), AstraZeneca PLC (NASDAQ:AZN), Pfizer (NYSE:PFE), Amgen (NASDAQ:AMGN), Bristol-Myers Squibb Co (NYSE:BMY), Gilead Sciences (NASDAQ:GILD), Biogen (NASDAQ:BIIB).

Industry description

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

Market Cap

The average market capitalization across the Pharmaceuticals: Major Industry is 79.5B. The market cap for tickers in the group ranges from 72.83K to 511B. LLY holds the highest valuation in this group at 511B. The lowest valued company is CRXTQ at 72.83K.

High and low price notable news

The average weekly price growth across all stocks in the Pharmaceuticals: Major Industry was -1%. For the same Industry, the average monthly price growth was -5%, and the average quarterly price growth was -5%. MIRA experienced the highest price growth at 8%, while SCLX experienced the biggest fall at -19%.

Volume

The average weekly volume growth across all stocks in the Pharmaceuticals: Major Industry was 14%. For the same stocks of the Industry, the average monthly volume growth was 23% and the average quarterly volume growth was 1%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 28
P/E Growth Rating: 59
Price Growth Rating: 57
SMR Rating: 57
Profit Risk Rating: 66
Seasonality Score: 30 (-100 ... +100)
View a ticker or compare two or three
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
A.I. Advisor
published Earnings

JNJ is expected to report earnings to fall 9.64% to $2.53 per share on October 17

Johnson & Johnson JNJ Stock Earnings Reports
Q3'23
Est.
$2.53
Q2'23
Beat
by $0.18
Q1'23
Beat
by $0.18
Q4'22
Beat
by $0.11
Q3'22
Beat
by $0.07
The last earnings report on July 20 showed earnings per share of $2.80, beating the estimate of $2.62. With 1.32M shares outstanding, the current market capitalization sits at 374.06B.
A.I.Advisor
published Dividends

JNJ paid dividends on September 07, 2023

Johnson & Johnson JNJ Stock Dividends
А dividend of $1.19 per share was paid with a record date of September 07, 2023, and an ex-dividend date of August 25, 2023. Read more...
A.I. Advisor
published General Information

General Information

an investment holding company with interests in health care products

Industry PharmaceuticalsMajor

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
One Johnson and Johnson Plaza
Phone
+1 732 524-0400
Employees
152700
Web
https://www.jnj.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
IZEA2.180.04
+1.87%
IZEA Worldwide
CRGY11.850.08
+0.68%
Crescent Energy Company
OB4.740.03
+0.64%
Outbrain
USB31.34-0.80
-2.49%
US Bancorp
LNC23.27-0.94
-3.88%
Lincoln National Corp

JNJ and

Correlation & Price change

A.I.dvisor indicates that over the last year, JNJ has been loosely correlated with MRK. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if JNJ jumps, then MRK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To JNJ
1D Price
Change %
JNJ100%
+0.12%
MRK - JNJ
62%
Loosely correlated
-0.76%
PFE - JNJ
59%
Loosely correlated
-0.12%
AMGN - JNJ
47%
Loosely correlated
-1.98%
BMY - JNJ
44%
Loosely correlated
-1.09%
ABBV - JNJ
43%
Loosely correlated
-0.55%
More

Groups containing JNJ

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To JNJ
1D Price
Change %
JNJ100%
+0.12%
inflammation
(undefined stocks)
72%
Closely correlated
-1.33%
covid-19 vaccine
(undefined stocks)
55%
Loosely correlated
-1.23%
oncology
(undefined stocks)
53%
Loosely correlated
-2.84%
seniors care
(undefined stocks)
52%
Loosely correlated
+0.74%
caring for seniors
(undefined stocks)
52%
Loosely correlated
+0.74%
More